Developing treatments to slow aging and provide dogs and cats with three to five or more years of additional healthy, youthful life.
Developing targeted therapies to promote healthy aging during mid-life.
Pre-clinical testing of promising interventions in mammalian models of severe mitochondrial disease, Parkinson’s disease, Alzheimer’s disease, diabetes, obesity and other conditions associated with mitochondrial dysfunction.
HALo stands as the centerpiece of an extremely rich environment for aging-related science at UW which is home to many leading centers of research, core facilities, and training opportunities for researchers in aging and its associated diseases.
Centers, Core Facilites & Training
Age is the single greatest risk factorfor most causes of death and disability. The odds of developing diabetes, heart disease, most cancers, kidney disease, dementia and many other conditions significantly increase in later life.
By understanding the mechanisms of biological aging at a molecular level, we have the opportunity to slow both the onset and progression of these disorders. The benefit to individuals will be the extension of healthspan — the period of life spent in good health, free from chronic disability and disorders. And the benefits to society will be significant, too.
New funding for three key projects would support important next steps — steps that could lead us closer to extending healthspan in people within a decade. We invite you to join us in supporting these exciting initiatives.
Photo by Clare McLean.